ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

In Brief: Delores Esparza President Elect Of ONS; Brown Demands Jako Retract “Insulting Remarks”

May 13, 1988

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

NCI awards $7.3 Million for Studies In Cancer communications

October 15, 1993

Cancer Meetings Listed

November 1, 1996